Client Success
We leverage our unparalleled relationships across the life sciences ecosystem to connect the right leaders with the right companies.
Recent Client Success
Filter by placement
CFO|August 30, 2023
Chief Financial Officer
Client Team Lead: John Spencer
Client: Telesis Bio Inc.
Telesis Bio Inc. (TBIO), a provider of automated multi-omic and synthetic biology solutions, said it has appointed William Kullback as its Chief Financial Officer, effective August 28.
In his new role, Kullback will be responsible for…
Telesis Bio Inc. (TBIO), a provider of automated multi-omic and synthetic biology solutions, said it has appointed William Kullback as its Chief Financial Officer, effective August 28.
In his new role, Kullback will be responsible for…
BOD|July 27, 2023
Board of Directors
Client Team Lead: John Spencer
Client: Velsera
Velsera, a healthcare technology company offering a universal software platform to connect clinical care with discovery, today announced the addition of Rachael Brake, PhD, and Ukonwa Ojo to its board of directors.
Brake is a distinguished scientist with more than…
Velsera, a healthcare technology company offering a universal software platform to connect clinical care with discovery, today announced the addition of Rachael Brake, PhD, and Ukonwa Ojo to its board of directors.
Brake is a distinguished scientist with more than…
BOD|July 24, 2023
Board of Directors
Client Team Lead: Matt Toner
Client: Allarity Therapeutics, Inc.
Allarity Therapeutics, Inc. (Allarity or the Company), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP® companion diagnostics for personalized cancer care, today announced the appointment of three seasoned biotechnology executives, Laura Benjamin, Ph.D.,…
Allarity Therapeutics, Inc. (Allarity or the Company), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP® companion diagnostics for personalized cancer care, today announced the appointment of three seasoned biotechnology executives, Laura Benjamin, Ph.D.,…
CCO|June 6, 2023
Chief Commercial Officer
Client Team Lead: John Spencer
Client: Nucleix.
Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, announced the appointment of commercial veteran, Michael G. Vicari, as Chief Commercial Officer.
At Nucleix, Mr. Vicari will build the company’s commercial team, preparing and…
Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, announced the appointment of commercial veteran, Michael G. Vicari, as Chief Commercial Officer.
At Nucleix, Mr. Vicari will build the company’s commercial team, preparing and…
CCO|June 6, 2023
Chief Commercial Officer
Client Team Lead: John Spencer
Client: G-Con Manufacturing, Inc.
G-CON, the global leader in off-site prefabricated cleanroom systems, today announced that it is expanding its commercial function following the recent launch of G-CON Clean Solutions, where it is now manufacturing and selling modular components to…
G-CON, the global leader in off-site prefabricated cleanroom systems, today announced that it is expanding its commercial function following the recent launch of G-CON Clean Solutions, where it is now manufacturing and selling modular components to…
CBO|June 5, 2023
Chief Business Officer
Client Team Lead: Andy Cronin
Client: Variant Bio
Variant Bio, a genomics-driven drug discovery company, is transitioning from a company that focused on identifying genomic variants that uncover the basis of disease resistance, to one that now also transforms those findings into therapies addressing…
Variant Bio, a genomics-driven drug discovery company, is transitioning from a company that focused on identifying genomic variants that uncover the basis of disease resistance, to one that now also transforms those findings into therapies addressing…
BOD|May 23, 2023
Chairman
Client Team Lead: Eric Simpson
Client: Cynerio
Healthcare cybersecurity leader, Cynerio, is proud to announce the appointment of Rasu B. Shrestha, MD, MBA as Chairman of the Board for Cynerio. Dr. Shrestha brings extensive experience in healthcare innovation and commercialization to Cynerio, including spearheading a…
Healthcare cybersecurity leader, Cynerio, is proud to announce the appointment of Rasu B. Shrestha, MD, MBA as Chairman of the Board for Cynerio. Dr. Shrestha brings extensive experience in healthcare innovation and commercialization to Cynerio, including spearheading a…
BOD|May 17, 2023
Board of Directors
Client Team Lead: Zach Charles
Client: Marinus Pharmaceuticals, Inc.
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the appointment of Sarah Noonberg, M.D., Ph.D., to its Board of Directors.
“Sarah is an…
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the appointment of Sarah Noonberg, M.D., Ph.D., to its Board of Directors.
“Sarah is an…
COO|May 8, 2023
Chief Operating Officer
Client Team Lead: John Spencer
Client: Guardant Health, Inc.
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the expansion of its leadership team with the addition of Ines Dahne-Steuber as chief operating officer and the promotion of Darya Chudova to chief…
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the expansion of its leadership team with the addition of Ines Dahne-Steuber as chief operating officer and the promotion of Darya Chudova to chief…
Learn More About Our Search Opportunities
Need help finding the right opportunity? We'll be happy to help!